NICE inquiry hears evidence

The process of providing guidance and approving drugs for the NHS is flawed and needs more engagement with experts, the Commons health select committee has heard in evidence in its inquiry into the National Institute for Health and Clinical Excellence.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Already a subscriber? Sign into your account here